» Articles » PMID: 28515093

Circulating Soluble P-selectin Must Dimerize to Promote Inflammation and Coagulation in Mice

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2017 May 19
PMID 28515093
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Leukocyte adhesion to P-selectin on activated platelets and endothelial cells induces shedding of the P-selectin ectodomain into the circulation. Plasma soluble P-selectin (sP-selectin) is elevated threefold to fourfold in patients with cardiovascular disease. Circulating sP-selectin is thought to trigger signaling in leukocytes that directly contributes to inflammation and thrombosis. However, sP-selectin likely circulates as a monomer, and in vitro studies suggest that sP-selectin must dimerize to induce signaling in leukocytes. To address this discrepancy, we expressed the entire ectodomain of mouse P-selectin as a monomer (sP-selectin) or as a disulfide-linked dimer fused to the Fc portion of mouse immunoglobulin G (sP-selectin-Fc). Dimeric sP-selectin-Fc, but not monomeric sP-selectin, triggered integrin-dependent adhesion of mouse leukocytes in vitro. Antibody-induced oligomerization of sP-selectin or sP-selectin-Fc was required to trigger formation of neutrophil extracellular traps. Injecting sP-selectin-Fc, but not sP-selectin, into mice augmented integrin-dependent adhesion of neutrophils in venules, generated tissue factor-bearing microparticles, shortened plasma-clotting times, and increased thrombus frequency in the inferior vena cava. Furthermore, transgenic mice that overexpressed monomeric sP-selectin did not exhibit increased inflammation or thrombosis. We conclude that elevated plasma sP-selectin is a consequence rather than a cause of cardiovascular disease.

Citing Articles

Inflammatory and Cardiovascular Responses to Active and Passive Acute Psychological Stress.

Linsley V, Bishop N, Roberts M, Hamrouni M, Demashkieh M, Paine N Biopsychosoc Sci Med. 2025; 87(2):107-117.

PMID: 39909009 PMC: 11801429. DOI: 10.1097/PSY.0000000000001367.


Sialyl Lewis Glycomimetics as E- and P-Selectin Antagonists Targeting Hyperinflammation.

Joyal M, Simard R, Maharsy W, Prevost M, Nemer M, Guindon Y ACS Med Chem Lett. 2025; 16(1):64-71.

PMID: 39811128 PMC: 11726361. DOI: 10.1021/acsmedchemlett.4c00452.


Rapid prediction of acute thrombosis via nanoengineered immunosensors with unsupervised clustering for multiple circulating biomarkers.

Wang K, Wang S, Margolis S, Cho J, Zhu E, Dupuy A Sci Adv. 2024; 10(50):eadq6778.

PMID: 39661669 PMC: 11633740. DOI: 10.1126/sciadv.adq6778.


Exploration on the effect of anserine on the alleviation of DVT and its molecular mechanism.

Li Y, Ge J, Yin Y, He J, Shang L Front Pharmacol. 2024; 15:1402758.

PMID: 38846090 PMC: 11154784. DOI: 10.3389/fphar.2024.1402758.


Proteomic profiling for biomarker discovery in heparin-induced thrombocytopenia.

Nilius H, Hamzeh-Cognasse H, Hastings J, Studt J, Tsakiris D, Greinacher A Blood Adv. 2024; 8(11):2825-2834.

PMID: 38588487 PMC: 11176969. DOI: 10.1182/bloodadvances.2024012782.


References
1.
Dole V, Bergmeier W, Patten I, Hirahashi J, Mayadas T, Wagner D . PSGL-1 regulates platelet P-selectin-mediated endothelial activation and shedding of P-selectin from activated platelets. Thromb Haemost. 2007; 98(4):806-12. View

2.
Ramachandran V, Yago T, Epperson T, Kobzdej M, Nollert M, Cummings R . Dimerization of a selectin and its ligand stabilizes cell rolling and enhances tether strength in shear flow. Proc Natl Acad Sci U S A. 2001; 98(18):10166-71. PMC: 56933. DOI: 10.1073/pnas.171248098. View

3.
McEver R . Selectins: initiators of leucocyte adhesion and signalling at the vascular wall. Cardiovasc Res. 2015; 107(3):331-9. PMC: 4592324. DOI: 10.1093/cvr/cvv154. View

4.
Johnston G, Bliss G, Newman P, McEver R . Structure of the human gene encoding granule membrane protein-140, a member of the selectin family of adhesion receptors for leukocytes. J Biol Chem. 1990; 265(34):21381-5. View

5.
Ridker P, Buring J, Rifai N . Soluble P-selectin and the risk of future cardiovascular events. Circulation. 2001; 103(4):491-5. DOI: 10.1161/01.cir.103.4.491. View